Literature DB >> 16144418

Asymmetric total syntheses of (-)-jorumycin, (-)-renieramycin G, 3-epi-jorumycin, and 3-epi-renieramycin G.

Jonathan W Lane1, Yuyin Chen, Robert M Williams.   

Abstract

The total synthesis of (-)-jorumycin (1) and (-)-renieramycin G (2) has been accomplished in 25 and 23 steps, respectively, from 5-benzyloxy-2,4-dimethoxy-3-methyl-benzyl alcohol. The synthesis features a substrate-tunable stereoselective intramolecular Pictet-Spengler-type reaction for the construction of the key pentacyclic core of both targets, bearing either the natural configuration or the epimeric configuration at C-3. With access to a C-3 epi-pentacyclic framework, 3-epi-jorumycin (32) and 3-epi-renieramycin G (34) were also successfully synthesized. Furthermore, preliminary biological evaluation of 3-epi-jorumycin (32), in addition to relevant synthetic intermediates, revealed that significant cytotoxicity had been retained in these compounds. Therefore, these early studies constitute the basis for a new structure activity relationship (SAR) investigation for this class of antitumor antibiotics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144418     DOI: 10.1021/ja0535918

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  11 in total

1.  Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G.

Authors:  Jonathan W Lane; Alberto Estevez; Kyle Mortara; Ondine Callan; Jeffrey R Spencer; Robert M Williams
Journal:  Bioorg Med Chem Lett       Date:  2006-05-02       Impact factor: 2.823

2.  Concise total syntheses of (-)-jorunnamycin A and (-)-jorumycin enabled by asymmetric catalysis.

Authors:  Eric R Welin; Aurapat Ngamnithiporn; Max Klatte; Guillaume Lapointe; Gerit M Pototschnig; Martina S J McDermott; Dylan Conklin; Christopher D Gilmore; Pamela M Tadross; Christopher K Haley; Kenji Negoro; Emil Glibstrup; Christian U Grünanger; Kevin M Allan; Scott C Virgil; Dennis J Slamon; Brian M Stoltz
Journal:  Science       Date:  2018-12-20       Impact factor: 47.728

3.  Regioselectivity of Pictet-Spengler Cyclization Reactions to Construct the Pentacyclic Frameworks of the Ecteinascidin-Saframycin Class of Tetrahydroisoquinoline Antitumor Antibiotics.

Authors:  Guillaume Vincent; Jonathan W Lane; Robert M Williams
Journal:  Tetrahedron Lett       Date:  2007-05-21       Impact factor: 2.415

4.  Syntheses of Highly Functionalized δ,γ-Unsaturated-α-Amino Acids.

Authors:  Siyuan Chen; Robert M Williams
Journal:  Tetrahedron       Date:  2006-12-11       Impact factor: 2.457

Review 5.  Natural products synthesis: enabling tools to penetrate Nature's secrets of biogenesis and biomechanism.

Authors:  Robert M Williams
Journal:  J Org Chem       Date:  2011-04-12       Impact factor: 4.354

6.  Identification of Non-Nucleoside Inhibitors of the Respiratory Syncytial Virus Polymerase Complex.

Authors:  Alberto Jiménez-Somarribas; Shuli Mao; Jeong-Joong Yoon; Marco Weisshaar; Robert M Cox; Jose R Marengo; Deborah G Mitchell; Zachary P Morehouse; Dan Yan; Ivan Solis; Dennis C Liotta; Michael G Natchus; Richard K Plemper
Journal:  J Med Chem       Date:  2017-03-13       Impact factor: 7.446

7.  Iridium-catalyzed allylation of chiral β-stereogenic alcohols: bypassing discrete formation of epimerizable aldehydes.

Authors:  Daniel C Schmitt; Anne-Marie R Dechert-Schmitt; Michael J Krische
Journal:  Org Lett       Date:  2012-12-11       Impact factor: 6.005

8.  Late-Stage Diversification: A Motivating Force in Organic Synthesis.

Authors:  Kelly E Kim; Alexia N Kim; Carter J McCormick; Brian M Stoltz
Journal:  J Am Chem Soc       Date:  2021-10-06       Impact factor: 16.383

9.  Synthetic studies on lemonomycin: construction of the tetracyclic core.

Authors:  Alberto Jiménez-Somarribas; Robert M Williams
Journal:  Tetrahedron       Date:  2013-09-02       Impact factor: 2.457

10.  Synthetic studies on Et-743. Assembly of the pentacyclic core and a formal total synthesis.

Authors:  Dan Fishlock; Robert M Williams
Journal:  J Org Chem       Date:  2008-12-19       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.